Clinical Trial Update: Celebrex - Cervix: Celecoxib in the Treatment of Patients With Locally Advanced Carcinoma of the Cervix [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update indicating the completion of a Phase 1/2 study of celecoxib (Celebrex) in locally advanced cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CELEBREX (Celecoxib)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Cervix Neoplasms | Phase 1, Phase 2 | Status: COMPLETED